Paper29449366
Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.
Hanson JLS and 6 others. Circ Heart Fail, 2018. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin. Papers, record 29449366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29449366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heart Failure | Major topic |
| Prealbumin | Major topic |
| Predictive Value of Tests | Major topic |
| ROC Curve | Major topic |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Proportional Hazards Models | |
| Retrospective Studies | |
| Ventricular Function, Left |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG031804 | NIA NIH HHS | United States | R01AG031804 | PubMed and NIH | NIH RePORTER |
| R56 AG031804 | NIA NIH HHS | United States | R01AG031804 | PubMed and NIH | NIH RePORTER |
| R56AG031804 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 29449369 | Serum Transthyretin: Predictor of Amyloidosis Outcomes? | https://conductscience.org/library/papers/29449369 |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14330531 | METABOLISM OF IODINE-131--LABELED THYROXINE-BINDING PREALBUMIN IN MAN. | Science | 1965 | https://conductscience.org/library/papers/14330531 | PubMed |
| 2 | 17378745 | Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition. | Clin Chem Lab Med | 2007 | https://conductscience.org/library/papers/17378745 | PubMed |
| 3 | 4038581 | Lowered prealbumin levels in patients with familial amyloid polyneuropathy (FAP) and their non-affected but at risk relatives. | Am J Med Sci | 1985 | https://conductscience.org/library/papers/4038581 | PubMed |
| 4 | 14746554 | The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. | J Intern Med | 2004 | https://conductscience.org/library/papers/14746554 | PubMed |
| 5 | 22620969 | Senile systemic amyloidosis: are regional differences real or do they reflect different diagnostic suspicion and use of techniques? | Amyloid | 2012 | https://conductscience.org/library/papers/22620969 | PubMed |
| 6 | 6090552 | Nephelometric measurement of human serum prealbumin and correlation with acute-phase proteins CRP and SAA: results in familial amyloid polyneuropathy. | J Lab Clin Med | 1984 | https://conductscience.org/library/papers/6090552 | PubMed |
| 7 | 3818577 | Analyses of prealbumin mRNAs in individuals with familial amyloidotic polyneuropathy. | J Biochem | 1986 | https://conductscience.org/library/papers/3818577 | PubMed |
| 8 | 24563469 | Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. | Circulation | 2014 | https://conductscience.org/library/papers/24563469 | PubMed |
| 9 | 25758359 | Cardiac amyloidosis: the great pretender. | Heart Fail Rev | 2015 | https://conductscience.org/library/papers/25758359 | PubMed |
| 10 | 22329529 | Transthyretin cardiac amyloidoses in older North Americans. | J Am Geriatr Soc | 2012 | https://conductscience.org/library/papers/22329529 | PubMed |
| 11 | 26610878 | Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis. | J Am Coll Cardiol | 2015 | https://conductscience.org/library/papers/26610878 | PubMed |
| 12 | 23193944 | THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. | Curr Med Res Opin | 2013 | https://conductscience.org/library/papers/23193944 | PubMed |
| 13 | 15983293 | Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. | Arch Intern Med | 2005 | https://conductscience.org/library/papers/15983293 | PubMed |
| 14 | 19065297 | Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity. | Amyloid | 2008 | https://conductscience.org/library/papers/19065297 | PubMed |
| 15 | 22645360 | Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22645360 | PubMed |
| 16 | 24368466 | Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. | JAMA | 2013 | https://conductscience.org/library/papers/24368466 | PubMed |
| 17 | 26660283 | Wild-Type Transthyretin Amyloid Cardiomyopathy: A Missed Cause of Heart Failure With Preserved Ejection Fraction With Evolving Treatment Implications. | Circulation | 2016 | https://conductscience.org/library/papers/26660283 | PubMed |
| 18 | 19752327 | Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. | Circulation | 2009 | https://conductscience.org/library/papers/19752327 | PubMed |
| 19 | 23608605 | Senile systemic amyloidosis: clinical features at presentation and outcome. | J Am Heart Assoc | 2013 | https://conductscience.org/library/papers/23608605 | PubMed |
| 20 | 16928339 | Cardiac amyloidosis: shifting our impressions to hopeful. | Curr Heart Fail Rep | 2006 | https://conductscience.org/library/papers/16928339 | PubMed |
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42769982 | The Arrhythmic Burden of Cardiac Amyloidosis: A Comprehensive Review. | Heart Views | 2026 | https://conductscience.org/library/papers/42769982 | PubMed |
| 42658464 | Impact of Tafamidis on Transthyretin Concentration and Its Relation to All-Cause Mortality in Patients with Transthyretin Amyloid Cardiomyopathy: An Analysis from ATTR-ACT. | Cardiol Ther | 2026 | https://conductscience.org/library/papers/42658464 | PubMed |
| 42622768 | ACO-SWITCH: Rationale and Design of a Phase 4 Study Evaluating Serum Transthyretin in ATTR-CM After Switching from Tafamidis to Acoramidis. | Cardiol Ther | 2026 | https://conductscience.org/library/papers/42622768 | PubMed |
| 42576135 | Transthyretin Amyloid Cardiomyopathy in Women: Epidemiology, Diagnostic Delay, and Clinical Implications. | Cardiol Ther | 2026 | https://conductscience.org/library/papers/42576135 | PubMed |
| 42326538 | Development of Human iPSC-based Microphysiogical Models of Transthyretin Amyloid Cardiomyopathy. | Res Sq | 2026 | https://conductscience.org/library/papers/42326538 | PubMed |
| 42307157 | Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis. | JACC CardioOncol | 2026 | https://conductscience.org/library/papers/42307157 | PubMed |
| 42305910 | Unveiling the unseen: navigating heart involvement in amyloidosis with biomarkers beyond the horizons of imaging. | Eur Heart J Imaging Methods Pract | 2026 | https://conductscience.org/library/papers/42305910 | PubMed |
| 42257495 | Evaluation of the Current ATTR-CM Treatment Landscape via a Mathematical Model of TTR Dissociation and Amyloid Formation. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42257495 | PubMed |
| 42228252 | Context-of-use-Guided Development and Validation of a Transthyretin Immunoassay: A Framework for Biomarker Assay Design. | AAPS J | 2026 | https://conductscience.org/library/papers/42228252 | PubMed |
| 42201475 | Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR Amyloidosis. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/42201475 | PubMed |
| 42132180 | Pathogenic Characterization of a Novel G47R Transthyretin Mutation in Early-Onset Amyloid Cardiomyopathy. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/42132180 | PubMed |
| 41776317 | Atrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations. | NPJ Cardiovasc Health | 2025 | https://conductscience.org/library/papers/41776317 | PubMed |
| 41734414 | Association Between Occupational Physical Work Exposure and Wild-Type Transthyretin Cardiomyopathy. | JACC Adv | 2026 | https://conductscience.org/library/papers/41734414 | PubMed |
| 41513988 | Phenomenological model of transthyretin stabilization. | Sci Rep | 2026 | https://conductscience.org/library/papers/41513988 | PubMed |
| 41088066 | Circulating transthyretin with atrial morpho-functional phenotypes and atrial fibrillation risk, and the modifying role of BMI. | BMC Med | 2025 | https://conductscience.org/library/papers/41088066 | PubMed |
| 40889301 | In vitro and in vivo disease models of cardiac amyloidosis: progress, pitfalls, and potential. | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/40889301 | PubMed |
| 40852192 | Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis. | Eur Heart J Open | 2025 | https://conductscience.org/library/papers/40852192 | PubMed |
| 40717228 | Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis. | Ann Med | 2025 | https://conductscience.org/library/papers/40717228 | PubMed |
| 40684004 | Current and Future Treatment Landscape of Transthyretin Amyloid Cardiomyopathy. | Cardiol Ther | 2025 | https://conductscience.org/library/papers/40684004 | PubMed |
| 40067885 | Initiation of transthyretin aggregation at neutral pH by fluid agitation. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40067885 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| NPPB | 4879 | PubTator's text mining | https://conductscience.org/library/genes/4879 | NCBI Gene |
| RBP4 | 5950 | PubTator's text mining | https://conductscience.org/library/genes/5950 | NCBI Gene |
| TNNI3 | 7137 | PubTator's text mining | https://conductscience.org/library/genes/7137 | NCBI Gene |
| TNNT2 | 7139 | PubTator's text mining | https://conductscience.org/library/genes/7139 | NCBI Gene |
| TTR | 7276 | PubTator's text mining | https://conductscience.org/library/genes/7276 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29449366
GET https://conductscience.org/api/papers/v1/29449366/references?page=2